Cutting Edge: Novel Priming of Tumor-Specific Immunity by NKG2D-Triggered NK Cell-Mediated Tumor Rejection and Th1-Independent CD4+ T Cell Pathway

Journal of Immunology - United States
doi 10.4049/jimmunol.172.2.757
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Cutting Edge: Tumor-Targeting Antibodies Enhance NKG2D-Mediated NK Cell Cytotoxicity by Stabilizing NK Cell-Tumor Cell Interactions

Journal of Immunology
AllergyImmunology
2012English

Interleukin 7 Induces CD4+ T Cell-Dependent Tumor Rejection

Journal of Experimental Medicine
MedicineAllergyImmunology
1991English

Impairment of NKG2D-Mediated Tumor Immunity by TGF-β

Frontiers in Immunology
AllergyImmunology
2019English

Cutting Edge: Activation of NK Cell-Mediated Cytotoxicity by a SAP-Independent Receptor of the CD2 Family

Journal of Immunology
AllergyImmunology
2001English

Antibody-Mediated Inhibition of MICA and MICB Shedding Promotes NK Cell–driven Tumor Immunity

Science
MultidisciplinaryPhilosophy of ScienceHistory
2018English

Increase of NKG2D Ligands and Sensitivity to NK Cell-Mediated Cytotoxicity of Tumor Cells by Heat Shock and Ionizing Radiation

Experimental & Molecular Medicine
2006English

Induction of Postsurgical Tumor Immunity and T-Cell Memory by a Poorly Immunogenic Tumor

Cancer Research
Cancer ResearchOncology
2007English

Cutting Edge: Thymic NK Cells Develop Independently From T Cell Precursors

Journal of Immunology
AllergyImmunology
2010English

Precise Spatio-Temporal Interruption of Regulatory T Cell-Mediated CD8+ T Cell Suppression Leads to Tumor Immunity

Cancer Research
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy